How to Get Lisinopril in Connecticut: Prescriptions, Telehealth, and Pharmacies

At a glance
- Drug class / ACE inhibitor (angiotensin-converting enzyme inhibitor)
- FDA-approved indications / hypertension, heart failure (adjunct), acute MI, diabetic nephropathy
- Prescription required / Yes, Schedule: none (non-controlled)
- Telehealth prescribing in CT / Permitted under Connecticut telehealth law
- Typical starting dose / 10 mg once daily for hypertension; 5 mg for heart failure
- Baseline labs required / BMP (creatinine, potassium, eGFR) before initiation
- Generic cost without insurance / $4-$15 per 30-day supply at most CT pharmacies
- Connecticut Medicaid (HUSKY) / Covered; PA required for heart failure and CKD indications in some cases
- 503A compounding in CT / Available through licensed Connecticut compounding pharmacies
- Time from consult to medication / As fast as same-day (telehealth) to 72 hours (mail-order)
What Is Lisinopril and Why Is It Prescribed?
Lisinopril is an ACE inhibitor approved by the FDA for hypertension, left ventricular dysfunction after myocardial infarction, and symptomatic heart failure as an adjunct to diuretics and digitalis [1]. It blocks the conversion of angiotensin I to angiotensin II, reducing peripheral vascular resistance and lowering blood pressure. The ALLHAT trial (N=33,357) remains the largest head-to-head antihypertensive comparison ever conducted; at five years, lisinopril reduced systolic blood pressure comparably to chlorthalidone and amlodipine, and the investigators concluded that "thiazide-type diuretics are superior in preventing one or more major forms of CVD and are less expensive... ACE inhibitors... remain appropriate for high-risk groups including those with diabetes or CKD" [2].
Lisinopril's once-daily dosing and proven renal-protective profile make it a first-line choice for patients with type 2 diabetes and microalbuminuria. The FDA label confirms dosing for hypertension begins at 10 mg once daily, with a maintenance range of 20 to 40 mg daily [1]. For heart failure, initiation at 5 mg daily is standard, titrating toward 40 mg based on tolerance [1].
Generic lisinopril is manufactured by multiple companies and costs $4 to $15 per 30-day supply at most Connecticut retail pharmacies, making it one of the most affordable prescription antihypertensives available [3].
Connecticut Telehealth Rules for Lisinopril Prescribing
Connecticut law fully permits telehealth prescribing of lisinopril. The Connecticut Telehealth Act (Public Act 21-133, codified at Conn. Gen. Stat. §19a-906) requires that a valid prescriber-patient relationship exist, but it does not require an in-person visit before a telehealth visit can establish that relationship [4]. A video or audio-visual encounter is sufficient for a clinician to evaluate blood pressure history, review prior labs, and issue a new prescription.
The prescriber must be licensed in Connecticut. Platforms serving Connecticut patients from out-of-state prescribers must hold a Connecticut license or use a licensed Connecticut clinician on their panel. The Connecticut Department of Public Health maintains an online license verification tool; patients should confirm their telehealth provider is listed before booking [5].
After a telehealth visit, electronic prescriptions (e-prescriptions) are sent directly to the patient's chosen pharmacy. Most major telehealth platforms transmit e-prescriptions within minutes of visit completion, meaning a patient could have a lisinopril prescription at a local pharmacy on the same day as their appointment.
During the telehealth visit, a clinician will typically review home blood pressure readings (at least two readings on two separate occasions), any prior labs, current medications, and contraindications such as a history of ACE inhibitor-induced angioedema, pregnancy, or bilateral renal artery stenosis. Patients with no recent bloodwork may be asked to complete a basic metabolic panel (BMP) before the prescription is released.
Which Clinicians Can Prescribe Lisinopril in Connecticut?
Licensed physicians (MD, DO), nurse practitioners (APRN), and physician assistants (PA) may all prescribe lisinopril in Connecticut. Each credential carries prescriptive authority for non-controlled substances without exception.
Connecticut APRNs operate under a collaborative agreement requirement for the first three years of practice, after which they may prescribe independently. The Connecticut APRN Practice Act (Conn. Gen. Stat. §20-87a) governs this timeline [6]. PAs in Connecticut prescribe under a supervision agreement with a supervising physician, but that agreement does not restrict them from prescribing antihypertensives such as lisinopril [6].
Pharmacists in Connecticut do not have independent prescriptive authority for lisinopril. They can, however, counsel patients on dose timing, food interactions, and expected side effects, and they can contact a prescriber directly if a refill authorization is needed.
HealthRX Prescriber-Match Framework for Connecticut Lisinopril Access
| Patient Situation | Recommended Route | Typical Time to Rx | |---|---|---| | New patient, no recent labs | Telehealth visit + same-day lab order | 24-48 hours to fill | | Established patient, labs within 12 months | Telehealth visit only | Same day | | Transferring from out-of-state provider | Pharmacy transfer or telehealth Rx renewal | 24-72 hours | | HUSKY Health (Medicaid) enrollee, hypertension | In-person or telehealth; verify PA status | 1-5 business days | | Uninsured, cash pay | GoodRx or direct-pay telehealth | Same day to 24 hours |
Required Labs Before Starting Lisinopril in Connecticut
Before initiating lisinopril, clinicians order a basic metabolic panel to assess baseline creatinine, potassium, and estimated glomerular filtration rate (eGFR). This is not a state-specific legal requirement; it reflects the standard of care supported by JNC 8 guidelines and the ACC/AHA 2017 hypertension guideline, which states that "serum creatinine and eGFR should be measured before starting ACE inhibitor therapy to establish a baseline for monitoring" [7].
Lisinopril is contraindicated when eGFR falls below 30 mL/min/1.73 m² in some formulary contexts, and dose reduction is recommended when eGFR is between 10 and 30 mL/min/1.73 m² [1]. Hyperkalemia risk is elevated in patients with baseline potassium above 5.0 mEq/L; clinicians will typically defer initiation until potassium normalizes [8].
A urine albumin-to-creatinine ratio (uACR) is ordered when diabetic nephropathy or CKD is the indication, because a reduction in albuminuria is the key therapeutic endpoint. The ADVANCE trial (N=11,140) demonstrated that ACE inhibitor-based therapy reduced the relative risk of new or worsening nephropathy by 21% in patients with type 2 diabetes [9].
Most commercial labs in Connecticut (Quest Diagnostics, LabCorp, Yale New Haven Health outpatient labs) return BMP results within 24 to 48 hours. Telehealth platforms typically send an electronic lab order to the patient's nearest draw site at the time of the visit, so blood can be drawn that same day.
Follow-up labs are ordered one to two weeks after initiation to detect any acute rise in creatinine or potassium. A creatinine increase of up to 30% from baseline is considered acceptable when starting an ACE inhibitor and does not mandate discontinuation according to current nephrology guidance [10].
How to Get a Lisinopril Prescription in Connecticut: Step by Step
Getting lisinopril starts with a clinical evaluation. The steps below reflect the standard pathway for a new patient using a telehealth service, which is the fastest route for most Connecticut residents.
Step 1. Schedule a telehealth or in-person visit. Book with a Connecticut-licensed MD, DO, NP, or PA. Telehealth platforms with Connecticut prescribers include national services (Teladoc, Hims/Hers, HealthRX) and Connecticut-specific primary care groups offering virtual visits.
Step 2. Complete intake forms. Submit your blood pressure log, current medications, allergy list, and any recent lab results. Most platforms accept uploaded PDFs or photos of lab printouts.
Step 3. Attend the clinical encounter. The visit typically lasts 15 to 20 minutes. The clinician reviews your cardiovascular risk, confirms the indication, and checks for contraindications.
Step 4. Complete baseline labs if needed. If you have no BMP within the past 12 months, the clinician sends an electronic order to a local draw site. Quest Diagnostics has over 30 patient service centers in Connecticut [11].
Step 5. Receive the e-prescription. Once labs are reviewed and acceptable, the e-prescription is transmitted to your pharmacy. No in-person return visit is required.
Step 6. Pick up or receive the medication. Local pharmacies fill same-day. Mail-order pharmacies (CVS Caremark, Express Scripts, Costco Pharmacy Mail Order) deliver within two to five business days.
Connecticut Medicaid (HUSKY Health) and Prior Authorization
Connecticut Medicaid, administered as HUSKY Health through the Department of Social Services, covers generic lisinopril on its preferred drug list (PDL). For the hypertension indication, generic ACE inhibitors including lisinopril are covered without prior authorization on most HUSKY Health managed care plans [12].
Prior authorization is required on some HUSKY Health plans when lisinopril is prescribed for heart failure or CKD with proteinuria as the primary coded indication. The PA process requires the prescriber to submit documentation of the diagnosis (ICD-10 code I50.x for heart failure or N18.x for CKD), current blood pressure readings, relevant lab values (creatinine, eGFR, uACR), and a statement that first-line agents have been considered [12].
PA requests submitted via CoverMyMeds or directly through the HUSKY Health managed care organization (Anthem, Aetna Better Health, or Wellcare) are typically decided within 72 hours for standard requests and 24 hours for urgent requests, per Connecticut state timelines for Medicaid PA decisions [13].
Denied PAs can be appealed. The Connecticut Insurance Department oversees external appeals and permits enrollees to request a standard appeal within 30 days of denial [13]. A physician-written letter of medical necessity citing the ALLHAT data and the ACC/AHA guideline recommendation for ACE inhibitors in diabetic hypertension significantly strengthens an appeal.
Pharmacy Options for Lisinopril in Connecticut
Generic lisinopril 10 mg (30-count) is available at every major pharmacy chain operating in Connecticut. Cash prices vary considerably by location and whether a discount card is applied.
Retail chains: CVS, Walgreens, Rite Aid, Stop and Shop, and Stop and Shop's affiliated pharmacies all carry generic lisinopril. Using GoodRx at CVS in Hartford, the price for 30 tablets of 10 mg lisinopril is approximately $4 to $9 as of mid-2025 [3].
Independent pharmacies: Connecticut has a strong independent pharmacy network, particularly in Bridgeport, New Haven, Stamford, and Hartford. Many offer 90-day supplies at reduced per-unit cost for uninsured patients.
Mail-order pharmacies: CVS Caremark, OptumRx, and Express Scripts all serve Connecticut addresses. A 90-day supply through mail-order typically costs $10 to $20 with most commercial insurance plans and ships with free standard delivery.
503A compounding pharmacies: Connecticut-licensed 503A compounding pharmacies can prepare lisinopril in alternative formulations (liquid suspension for patients with dysphagia, for example) when a standard commercial tablet is clinically unsuitable. The FDA defines 503A pharmacies as those compounding for an individual patient based on a valid prescription, distinct from 503B outsourcing facilities [14]. Connecticut's Department of Consumer Protection pharmacy licensing portal lists all currently licensed pharmacies in the state, including those with compounding certifications [5].
503A pharmacies in Connecticut may ship compounded lisinopril preparations within the state when a valid prescription from a Connecticut-licensed prescriber accompanies the order. Interstate shipping of compounded preparations follows federal DSCSA rules and is subject to additional restrictions [14].
Transferring a Lisinopril Prescription to Connecticut
Patients relocating to Connecticut, whether permanently or temporarily, can transfer an existing lisinopril prescription from an out-of-state pharmacy to a Connecticut pharmacy. Under federal law and Connecticut pharmacy regulations, a pharmacist may transfer a prescription for a non-controlled substance one time from the original dispensing pharmacy to the receiving Connecticut pharmacy [15].
To initiate a transfer: call the Connecticut pharmacy you want to use, provide the name and phone number of your current pharmacy, and the Connecticut pharmacist will contact the originating pharmacy directly. The transfer is typically completed within a few hours on the same business day.
If your prescription has no remaining refills, the Connecticut pharmacist can contact your out-of-state prescriber for a new authorization, or you can schedule a telehealth visit with a Connecticut-licensed prescriber to obtain a new prescription with Connecticut-compliant e-prescribing.
Patients who move to Connecticut and need an immediate supply while arranging a new prescriber can ask their Connecticut pharmacist for an emergency supply. Connecticut General Statutes §20-633b permits a pharmacist to dispense an emergency supply of a chronic medication such as lisinopril when a refill cannot be obtained promptly, typically up to a 30-day supply [15].
Side Effects, Monitoring, and When to Seek Care
The most clinically significant adverse effects of lisinopril are ACE inhibitor-induced cough (reported in 5 to 20% of patients), hyperkalemia, acute kidney injury, and angioedema [1]. Angioedema is rare, affecting approximately 0.1 to 0.5% of patients, but requires immediate discontinuation and emergency evaluation if it involves the tongue, lips, or throat [16].
The ACC/AHA 2017 hypertension guideline states: "ACE inhibitors should not be used in patients with a history of ACE inhibitor-induced angioedema or in patients who are pregnant" [7]. This contraindication is absolute.
Persistent dry cough is the most common reason patients discontinue lisinopril. For those who cannot tolerate the cough, angiotensin receptor blockers (ARBs) such as losartan or valsartan are a standard alternative class offering similar blood pressure reduction without bradykinin accumulation, the mechanism responsible for ACE inhibitor cough [17].
Potassium should be rechecked one to two weeks after initiation and after any dose change. Patients taking concurrent potassium-sparing diuretics (spironolactone, eplerenone), trimethoprim-sulfamethoxazole, or NSAIDs face elevated hyperkalemia risk and warrant closer monitoring intervals [8].
Blood pressure response is typically measurable within one to two weeks. A 2020 meta-analysis in the Journal of the American College of Cardiology (N=348 trials, N=444,325 participants) found that each 5 mmHg reduction in systolic blood pressure was associated with approximately a 10% reduction in major cardiovascular events, independent of drug class [18].
Cost Assistance and Patient Support Programs
Generic lisinopril is inexpensive enough that most patients do not need manufacturer assistance programs. At $4 to $15 per 30-day supply with GoodRx or similar discount cards, out-of-pocket cost is manageable for most uninsured patients [3].
For patients enrolled in Medicare Part D, lisinopril is on Tier 1 of most plan formularies, meaning the copay is typically $0 to $5 per month. The Medicare Extra Help program (Low Income Subsidy) covers or eliminates cost-sharing for qualifying beneficiaries [19].
Connecticut also operates the Connecticut Pharmaceutical Assistance Contract to the Elderly and Disabled (PACE/PACPLUS) program, administered through the Department of Social Services, which subsidizes drug costs for income-qualifying residents aged 65 and older or those receiving Social Security Disability [20]. PACE covers generic antihypertensives including lisinopril for eligible enrollees.
For patients whose commercial insurance has a high deductible, GoodRx Gold ($9.99/month membership) and Mark Cuban's Cost Plus Drugs (costplusdrugs.com) both list lisinopril at well under $10 per 30-day supply without insurance involvement.
Frequently asked questions
›How do I get a lisinopril prescription in Connecticut?
›What labs are needed before lisinopril in Connecticut?
›Are there telehealth providers in Connecticut prescribing lisinopril?
›How long until I receive lisinopril in Connecticut?
›Can I transfer a lisinopril prescription to Connecticut?
›Are 503A pharmacies in Connecticut licensed to ship lisinopril?
›Who can prescribe lisinopril in Connecticut: MD vs NP vs PA?
›What documentation does prior authorization require in Connecticut?
References
- U.S. Food and Drug Administration. Lisinopril tablets prescribing information. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019777
- ALLHAT Officers and Coordinators. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. JAMA. 2002;288(23):2981-2997. https://pubmed.ncbi.nlm.nih.gov/12479763/
- GoodRx. Lisinopril prices and coupons. https://www.goodrx.com/lisinopril
- Connecticut General Assembly. Public Act 21-133: An Act Concerning Telehealth. https://www.cga.ct.gov/2021/act/Pa/pdf/2021PA-00133-R00SB-00896-PA.PDF
- Connecticut Department of Public Health. License verification. https://www.elicense.ct.gov/
- Connecticut General Assembly. Conn. Gen. Stat. §20-87a: APRN practice. https://www.cga.ct.gov/current/pub/chap_378.htm
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA hypertension guideline. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29146535/
- Palmer BF, Clegg DJ. Physiology and pathophysiology of potassium homeostasis. Adv Physiol Educ. 2016;40(4):480-490. https://pubmed.ncbi.nlm.nih.gov/27756725/
- ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560-2572. https://pubmed.ncbi.nlm.nih.gov/18539916/
- Bakris GL, Weir MR. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine. Arch Intern Med. 2000;160(5):685-693. https://pubmed.ncbi.nlm.nih.gov/10724055/
- Quest Diagnostics. Patient service center locator. https://www.questdiagnostics.com/home/patients/psc/
- Connecticut Department of Social Services. HUSKY Health preferred drug list. https://www.huskyhealthct.org/
- Connecticut Insurance Department. Prior authorization and appeals. https://portal.ct.gov/CID
- U.S. Food and Drug Administration. Compounding laws and policies: 503A and 503B. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
- Connecticut General Assembly. Conn. Gen. Stat. §20-633b: Emergency dispensing. https://www.cga.ct.gov/current/pub/chap_400j.htm
- Kostis JB, Kim HJ, Rusnak J, et al. Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med. 2005;165(14):1637-1642. https://pubmed.ncbi.nlm.nih.gov/16043683/
- Granger CB, McMurray JJ, Yusuf S, et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to ACE inhibitors: the CHARM-Alternative trial. Lancet. 2003;362(9386):772-776. https://pubmed.ncbi.nlm.nih.gov/13678870/
- Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death. Lancet. 2016;387(10022):957-967. https://pubmed.ncbi.nlm.nih.gov/26724178/
- Centers for Medicare and Medicaid Services. Extra Help with Medicare prescription drug plan costs. https://www.medicare.gov/your-medicare-costs/get-help-paying-costs/extra-help
- Connecticut Department of Social Services. PACE and PACPLUS programs. https://www.ct.gov/dss/cwp/view.asp?a=2353&q=305172